NO20062202L - Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromene-6-yl derivatives, processes and intermediates for their preparation, and drugs containing these compounds - Google Patents

Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromene-6-yl derivatives, processes and intermediates for their preparation, and drugs containing these compounds

Info

Publication number
NO20062202L
NO20062202L NO20062202A NO20062202A NO20062202L NO 20062202 L NO20062202 L NO 20062202L NO 20062202 A NO20062202 A NO 20062202A NO 20062202 A NO20062202 A NO 20062202A NO 20062202 L NO20062202 L NO 20062202L
Authority
NO
Norway
Prior art keywords
compounds
intermediates
amidomethyl
chromene
sulfonylamino
Prior art date
Application number
NO20062202A
Other languages
Norwegian (no)
Inventor
Dieter Ziegler
Michael Weske
Yvan Fischer
David Sykes
Brian Moloney
Lester Marrison
Michael Mlinaric
Christiane Boecker
Reinhard Brueckner
Klaus Witte
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO20062202L publication Critical patent/NO20062202L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det er beskrevet forbindelser med den generelle formel (I) hvor R1, R2, R3, R4, R5 og R6 har de i beskrivelsen angitte betydninger, samt en fremgangsmåte for fremstilling av disse forbindelsene og mellomprodukter i denne fremgangsmåten. Videre er det angitt legemidler som inneholder forbindelsene med formel (I).Compounds of general formula (I) are described, wherein R 1, R 2, R 3, R 4, R 5 and R 6 have the meanings set forth in the specification, as well as a process for preparing these compounds and intermediates in this process. Further, drugs are disclosed which contain the compounds of formula (I).

NO20062202A 2003-10-17 2006-05-16 Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromene-6-yl derivatives, processes and intermediates for their preparation, and drugs containing these compounds NO20062202L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10348298A DE10348298A1 (en) 2003-10-17 2003-10-17 Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, processes and intermediates for their preparation, and medicaments containing these compounds
PCT/EP2004/052539 WO2005037780A2 (en) 2003-10-17 2004-10-14 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds

Publications (1)

Publication Number Publication Date
NO20062202L true NO20062202L (en) 2006-07-03

Family

ID=34442032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062202A NO20062202L (en) 2003-10-17 2006-05-16 Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromene-6-yl derivatives, processes and intermediates for their preparation, and drugs containing these compounds

Country Status (25)

Country Link
EP (1) EP1678130B1 (en)
JP (1) JP4791968B2 (en)
KR (1) KR20060129170A (en)
CN (1) CN100532375C (en)
AR (1) AR046106A1 (en)
AT (1) ATE405547T1 (en)
AU (1) AU2004281195B2 (en)
BR (1) BRPI0415523A (en)
CA (1) CA2542813C (en)
DE (3) DE10348298A1 (en)
DK (1) DK1678130T3 (en)
ES (1) ES2313126T3 (en)
HK (1) HK1096960A1 (en)
HR (1) HRP20080602T3 (en)
IL (1) IL174950A (en)
MX (1) MXPA06003958A (en)
NO (1) NO20062202L (en)
PL (1) PL1678130T3 (en)
PT (1) PT1678130E (en)
RU (1) RU2355685C2 (en)
SI (1) SI1678130T1 (en)
TW (1) TWI321564B (en)
UA (1) UA82907C2 (en)
WO (1) WO2005037780A2 (en)
ZA (1) ZA200602788B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006016420D1 (en) * 2005-04-12 2010-10-07 Abbott Products Gmbh AMINO ALKYLAMIDOMETHYL SUBSTITUTED 2- (4-SULFONYLAMINO) -3-HYDROXY-3,4-DIHYDRO-2H-CROMEN-6-YL DERIVATIVES AND THEIR USE AS COLUMN CHANNEL BLOCKERS
US7714150B2 (en) 2005-04-12 2010-05-11 Solvay Pharmaceuticals Gmbh Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
CA2615440A1 (en) * 2005-07-22 2007-02-08 Merck & Co., Inc. Potassium channel inhibitors
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
NO3175985T3 (en) 2011-07-01 2018-04-28
US20150045305A1 (en) 2012-01-27 2015-02-12 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
WO2014134419A1 (en) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Use of ikach blockers for the treatment of cardiac diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ282172B6 (en) * 1992-11-30 1997-05-14 Smithkline Beecham Plc Benzopyran analogs process for preparing such compounds, pharmaceutical composition containing such compounds and the use thereof
DE19546736A1 (en) * 1995-12-14 1997-06-19 Hoechst Ag Substituted chromanylsulfonyl (thio) ureas, process for their preparation and their use in the manufacture of pharmaceutical preparations
CA2341678C (en) * 1998-09-01 2009-10-13 Bristol-Myers Squibb Company Potassium channel inhibitors and method
JP2000336085A (en) * 1999-03-25 2000-12-05 Nissan Chem Ind Ltd Chroman derivative
AU2830800A (en) * 1999-03-25 2000-10-16 Nissan Chemical Industries Ltd. Chroman derivatives
EP1240147A1 (en) * 1999-12-21 2002-09-18 Icagen, Inc. Potassium channel inhibitors

Also Published As

Publication number Publication date
UA82907C2 (en) 2008-05-26
IL174950A0 (en) 2006-08-20
KR20060129170A (en) 2006-12-15
AU2004281195A1 (en) 2005-04-28
JP4791968B2 (en) 2011-10-12
TW200523259A (en) 2005-07-16
CN100532375C (en) 2009-08-26
HRP20080602T3 (en) 2008-12-31
PT1678130E (en) 2008-10-08
EP1678130A2 (en) 2006-07-12
DE10348298A1 (en) 2005-05-19
BRPI0415523A (en) 2006-12-26
EP1678130B1 (en) 2008-08-20
AU2004281195B2 (en) 2010-12-16
TWI321564B (en) 2010-03-11
MXPA06003958A (en) 2006-07-05
DE502004007916D1 (en) 2008-10-02
RU2006116629A (en) 2007-11-27
SI1678130T1 (en) 2008-12-31
IL174950A (en) 2010-06-30
CA2542813A1 (en) 2005-04-28
CN1894233A (en) 2007-01-10
ES2313126T3 (en) 2009-03-01
DK1678130T3 (en) 2008-12-01
AU2004281195A2 (en) 2005-04-28
DE112004001659D2 (en) 2006-08-10
WO2005037780A3 (en) 2007-10-18
ZA200602788B (en) 2008-01-30
RU2355685C2 (en) 2009-05-20
HK1096960A1 (en) 2007-06-15
JP2007516235A (en) 2007-06-21
CA2542813C (en) 2011-08-30
PL1678130T3 (en) 2009-01-30
AR046106A1 (en) 2005-11-23
ATE405547T1 (en) 2008-09-15
WO2005037780A2 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
NO20062202L (en) Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromene-6-yl derivatives, processes and intermediates for their preparation, and drugs containing these compounds
NO20045369L (en) New, substituted sulfamate anticonvulsant derivatives
NO20054329L (en) Adamantan derivatives, processes for their preparation, and pharmaceutical compositions which include them
NO20055688L (en) Organic compounds
NO20054220L (en) Substituted N-aryl heterocycles, process for their preparation and their use as a drug
WO2005018557A3 (en) Substituted pyridinones
WO2004074244A3 (en) Pyrimidine compounds
NO20006251L (en) Benzothiepine-1,1-dioxide derivatives, process for their preparation, medicaments containing these compounds and their use
SE0202539D0 (en) Compounds
SE0104140D0 (en) Novel Compounds
ATE497957T1 (en) PYRIDINE DERIVATIVES AS FUNGICIDAL COMPOUNDS
NO20055092L (en) Substituted pyrimid ions
NO20070557L (en) Phthalazine derivatives as PARP inhibitors
TW200640900A (en) 1-(2h)-isoquinolone derivative
SE0200920D0 (en) Novel compounds
NO20062256L (en) Hydroxyalkyl-substituted pyrido-7-pyrimidin-7-ones
NO20053809L (en) Diarylmethylindenepiperidine derivatives, process for their preparation, and use thereof
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
NO20045486L (en) New compounds and their use
NO20065327L (en) Process for the preparation of derivatives of 5- [4- (2-hydroxy-propyl) -3,5-dihydro-3H'1, 2,4 (triazin-2-yl) -benzamide.
NO20076145L (en) Ureadeviates, processes for their preparation and use thereof
TW200510317A (en) Caspase inhibitors and uses thereof
HK1089746A1 (en) Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
NO20061045L (en) imidazole
DE602004031410D1 (en) INDIVIDUAL DERIVATIVES AS PHARMACEUTICALS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application